In light of the impact from SARS-CoV-2 and COVID-19, we have seen an increasing demand for reagents essential to lateral flow assays and point-of-care test development from our customers. Rapid diagnosis is a critical tool for screening at-risk populations and managing the spread of the outbreak. Development of sensitive lateral flow assays requires high performance, robust gold particles, and our BioReady gold reagents are a key component for maximizing the sensitivity and reliability of visual detection point of care tests.
Given the growing demand, we would like to support our customers in efforts to address the global community’s urgent need for rapid point-of-care testing by offering 50% off our Conjugation Kits.
Sign up to get the latest news from nanoComposix
© 2020 Nanocomposix.eu.